Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Genome-wide gene expression in a pharmacological hormonal transition model and its relation to depressive symptoms

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. New drug candidates for depression - a nationwide population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. One-Year Follow-up on Liraglutide Treatment for Prediabetes and Overweight/Obesity in Clozapine- or Olanzapine-Treated Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mortality in unipolar depression preceding and following chronic somatic diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Perinatal Depression: Embracing Variability toward Better Treatment and Outcomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Patients' attitudes and preferences towards a freeze-all strategy in ART treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Delirium assessment in neuro-critically ill patients: A validation study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Night work and sick leave during pregnancy: a national register-based within-worker cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVES: Sensitivity to sex-steroid hormone fluctuations may increase risk for perinatal depression. We aimed to identify genome-wide biological profiles in women demonstrating sensitivity to pharmacological sex-hormone manipulation with gonadotrophin-releasing hormone agonist (GnRHa).

METHODS: Longitudinal gene expression (Illumina Human HT12.v4) and DNA methylation data (Infinium HumanMethylation450K BeadChip) from 60 women (30 GnRHa, 30 placebo) were generated (Trial ID: NCT02661789). Differences between baseline and two follow-up points (initial stimulation- and subsequent early suppression phase) in the biphasic ovarian hormone response to GnRHa were assessed using linear mixed effects models.

RESULTS: Genome-wide analysis revealed 588 probes differentially expressed from GnRHa intervention to first stimulatory phase follow-up (intervention group × time) after 10% fdr multiple testing correction. Of these, 54% genes were also significantly associated with estradiol changes over time (proxy for GnRHa response magnitude), 9.5% were associated with changes in depressive symptoms, and 38% were associated with changes in neocortical serotonin transporter binding. The genes were implicated in TGF beta signaling, adipogenesis, regulation of actin cytoskeleton, and focal adhesion pathways and enriched for DNA methylation changes (P = 0.006).

CONCLUSIONS: These findings point toward an altered peripheral blood transcriptomic landscape in a pharmacological model of sex-hormone-induced depressive symptoms.

Original languageEnglish
JournalActa Psychiatrica Scandinavica
ISSN0001-690X
DOIs
Publication statusE-pub ahead of print - 17 May 2019

ID: 57325156